On Tuesday, Roivant Sciences Ltd (NASDAQ: ROIV) opened higher 0.35% from the last session, before settling in for the closing price of $11.5. Price fluctuations for ROIV have ranged from $8.73 to $13.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -99.51% over the past five years. Company’s average yearly earnings per share was noted -397.39% at the time writing. With a float of $418.04 million, this company’s outstanding shares have now reached $695.94 million.
Let’s look at the performance matrix of the company that is accounted for 750 employees. In terms of profitability, gross margin is 92.05%, operating margin of -1340.3%, and the pretax margin is -776.7%.
Roivant Sciences Ltd (ROIV) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Roivant Sciences Ltd is 38.51%, while institutional ownership is 71.21%. The most recent insider transaction that took place on Jun 20 ’25, was worth 1,145,000. In this transaction President & COO of this company sold 100,000 shares at a rate of $11.45, taking the stock ownership to the 1,462,223 shares. Before that another transaction happened on Jun 20 ’25, when Company’s 10% Owner sold 577,007 for $11.46, making the entire transaction worth $6,612,500. This insider now owns 37,284,108 shares in total.
Roivant Sciences Ltd (ROIV) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -397.39% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Check out the current performance indicators for Roivant Sciences Ltd (ROIV). In the past quarter, the stock posted a quick ratio of 33.47. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 102.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Roivant Sciences Ltd (NASDAQ: ROIV) saw its 5-day average volume 8.99 million, a positive change from its year-to-date volume of 5.86 million. As of the previous 9 days, the stock’s Stochastic %D was 67.00%.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 91.09%, which indicates a significant increase from 70.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.97% in the past 14 days, which was lower than the 34.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.98, while its 200-day Moving Average is $11.24. Nevertheless, the first resistance level for the watch stands at $11.75 in the near term. At $11.96, the stock is likely to face the second major resistance level. The third major resistance level sits at $12.10. If the price goes on to break the first support level at $11.40, it is likely to go to the next support level at $11.26. Assuming the price breaks the second support level, the third support level stands at $11.05.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are currently 679,806K shares outstanding in the company with a market cap of 7.84 billion. Presently, the company’s annual sales total 29,050 K according to its annual income of -171,980 K. Last quarter, the company’s sales amounted to 9,020 K and its income totaled 169,380 K.
